Monitoring Metabolic Side Effects When Initiating Treatment With Second-Generation Antipsychotic Medication

Clinical Schizophrenia and Related Psychoses - United States
doi 10.3371/csrp.5.4.4
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Walsh Medical Media, LLC